https://orcid.org/0009-0002-6986-8484
Abstract
We found that 8 of 10 patients with aplastic anemia experienced resolution of platelet transfusion refractoriness following daratumumab administration. Notably, 4 responders achieved hematopoietic recovery, including 3 participants who showed improvements in multilineage blood cell counts, even with daratumumab monotherapy. This trial was registered at www.clinicaltrials.gov as #NCT05832216.
References
1.
Trial to Reduce Alloimmunization to Platelets Study Group
. Leukocyte reduction and ultraviolet B irradiation of platelets to prevent alloimmunization and refractoriness to platelet transfusions
. N Engl J Med
. 1997
;337
(26
):1861
-1869
.2.
Liu
Y
, Zhang
Y
, Chen
D
, Fu
Y
. Current status of and global trends in platelet transfusion refractoriness from 2004 to 2021: a bibliometric analysis
. Front Med (Lausanne)
. 2022
;9
:873500
.3.
Song
X
, Qi
J
, Li
X
, et al. Exploration of risk factors of platelet transfusion refractoriness and its impact on the prognosis of hematopoietic stem cell transplantation: a retrospective study of patients with hematological diseases
. Platelets
. 2023
;34
(1
):2229905
.4.
Yankee
RA
, Graff
KS
, Dowling
R
, Henderson
ES
. Selection of unrelated compatible platelet donors by lymphocyte HL-A matching
. N Engl J Med
. 1973
;288
(15
):760
-764
.5.
Jia
Y
, Li
W
, Liu
N
, et al. Prevalence of platelet-specific antibodies and efficacy of crossmatch-compatible platelet transfusions in refractory patients
. Transfus Med
. 2014
;24
(6
):406
-410
.6.
Chen
SH
, Liang
DC
, Lin
M
. Treatment of platelet alloimmunization with intravenous immunoglobulin in a child with aplastic anemia
. Am J Hematol
. 1995
;49
(2
):165
-166
.7.
Yu
QH
, Shen
YP
, Ye
BD
, Zhou
YH
. Successful use of rituximab in platelet transfusion refractoriness in a multi-transfused patient with myelodysplastic syndrome
. Platelets
. 2015
;26
(2
):195
-196
.8.
Cid
J
, Magnano
L
, Acosta
M
, Alba
C
, Esteve
J
, Lozano
M
. Rituximab, plasma exchange and intravenous immunoglobulins as a new treatment strategy for severe HLA alloimmune platelet refractoriness
. Platelets
. 2015
;26
(2
):190
-194
.9.
Mauro
M
, Camoglio
F
, Piccoli
P
, et al. The use of splenectomy to manage platelet transfusion refractoriness due to anti-human leukocyte antibodies in allogeneic stem cell transplantation
. Pediatr Rep
. 2016
;8
(1
):6159
.10.
Bensinger
WI
, Buckner
CD
, Clift
RA
, Slichter
SJ
, Thomas
ED
. Plasma exchange for platelet alloimmunization
. Transplantation
. 1986
;41
(5
):602
-605
.11.
Gao
M
, Huang
J
, Shao
Y
, et al. Efficacy of anti-thymocyte globulin for platelet transfusion refractoriness in serious aplastic anemia patients
. Transfus Apher Sci
. 2022
;61
(3
):103376
.12.
Vo
P
, Purev
E
, West
KA
, et al. A pilot trial of complement inhibition using eculizumab to overcome platelet transfusion refractoriness in human leukocyte antigen allo-immunized patients
. Br J Haematol
. 2020
;189
(3
):551
-558
.13.
Panch
SR
, Guo
L
, Vassallo
R
. Platelet transfusion refractoriness due to HLA alloimmunization: evolving paradigms in mechanisms and management
. Blood Rev
. 2023
;62
:101135
.14.
Arthur
CM
, Patel
SR
, Sullivan
HC
, et al. CD8+ T cells mediate antibody-independent platelet clearance in mice
. Blood
. 2016
;127
(14
):1823
-1827
.15.
Muñoz
P
, Mittelbrunn
M
, de la Fuente
H
, et al. Antigen-induced clustering of surface CD38 and recruitment of intracellular CD38 to the immunologic synapse
. Blood
. 2008
;111
(7
):3653
-3664
.16.
Partida-Sánchez
S
, Goodrich
S
, Kusser
K
, Oppenheimer
N
, Randall
TD
, Lund
FE
. Regulation of dendritic cell trafficking by the ADP-ribosyl cyclase CD38: impact on the development of humoral immunity
. Immunity
. 2004
;20
(3
):279
-291
.17.
Piedra-Quintero
ZL
, Wilson
Z
, Nava
P
, Guerau-de-Arellano
M
. CD38: an immunomodulatory molecule in inflammation and autoimmunity
. Front Immunol
. 2020
;11
:597959
.18.
Chen
Y
, Xu
Y
, Li
H
, et al. A novel anti-CD38 monoclonal antibody for treating immune thrombocytopenia
. N Engl J Med
. 2024
;390
(23
):2178
-2190
.19.
Migdady
Y
, Ediriwickrema
A
, Jackson
RP
, et al. Successful treatment of thrombocytopenia with daratumumab after allogeneic transplant: a case report and literature review
. Blood Adv
. 2020
;4
(5
):815
-818
.20.
Stanworth
SJ
, Navarrete
C
, Estcourt
L
, Marsh
J
. Platelet refractoriness--practical approaches and ongoing dilemmas in patient management
. Br J Haematol
. 2015
;171
(3
):297
-305
.21.
Chinese Society of Hematology, Chinese Medical Association
. Chinese expert consensus on the diagnosis and management of platelet transfusion refractoriness (2022) [in Chinese].
. Zhonghua Xue Ye Xue Za Zhi
. 2022
;43
(11
):897
-902
.22.
Han
MH
, Badami
KG
. ABO non-identical platelet transfusions, immune platelet refractoriness and platelet support
. Br J Haematol
. 2024
;204
(5
):2097
-2102
.23.
Young
NS
. Aplastic anemia
. N Engl J Med
. 2018
;379
(17
):1643
-1656
.24.
You
X
, Yang
Q
, Yan
K
, et al. Multi-omics profiling identifies pathways associated with CD8+ T-cell activation in severe aplastic anemia
. Front Genet
. 2021
;12
:790990
.© 2025 American Society of Hematology. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.
2025
You do not currently have access to this content.
This feature is available to Subscribers Only
Sign In or Create an Account Close Modal